PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3010/1/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo ruled in breach for omitting key SPC warning in Lixiana (edoxaban) promotional guides
Bristol-Myers Squibb and Pfizer (the Alliance) complained about Daiichi-Sankyo’s promotion of Lixiana (edoxaban), a DOAC for NVAF. The Alliance alleged a consistent omission in promotional materi…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3053/7/18
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Anonymous doctor v Daiichi-Sankyo
An anonymous, contactable doctor complained about travel arrangements for a US-based health professional speaking at a June 2018 meeting organised by a Daiichi-Sankyo representative.The speaker (an…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3028/3/18
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AbbVie
A contactable ex-employee complained about (1) the production and promotion of an Embrace Stars poster and (2) the use of case studies at regional Embrace meetings. The poster related to Synagis (p…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3018/2/18
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Tesaro
Tesaro UK identified (via an internal email in Feb 2018) that seven hard-copy promotional items for Zejula (niraparib) might have been distributed to the field team before certification of their fi…
Clauses: 9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3025/3/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A member of the public made a complaint concerning the promotion of Nexplanon.The complaint was received on 13 March 2018.The case was considered under the ABPI Code of Practice 2016.
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3019/2/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Boehringer Ingelheim
An anonymous complainant raised a concern about a meeting advertised on LinkedIn.The company involved was Boehringer Ingelheim.The case was considered under the ABPI Code of Practice (Applicable Co…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3020/2/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Lilly
An anonymous complainant raised a concern about a meeting advertised on LinkedIn.The company involved was Lilly.The case was assessed under the ABPI Code of Practice 2016.
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3015/1/18
Data & Publications Upheld 🏥 Other ▶ Video 🎙 Podcast
Daiichi-Sankyo voluntary admission
Daiichi-Sankyo UK discovered (and voluntarily admitted) that three medical staff acted as nominated signatories before their names and qualifications were notified in advance to the MHRA and the PM…
Clauses: 9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3014/1/18
HCP Hospitality & Meetings Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
GW Pharmaceuticals
An anonymous, non-contactable complainant (self-described health professional) alleged GW Pharmaceuticals promoted Epidiolex (cannabidiol) at the British Paediatric Neurology Association (BPNA) mee…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3016/1/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Takeda
A consultant haematologist made a complaint against Takeda.The allegation related to religious discrimination.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3138/12/18
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Indivior
An ex-employee alleged Indivior did not disclose 2017 payments to health professionals, donations or sponsorships in the UK (and referenced missing historic website disclosures).Indivior said it ha…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3013/1/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca employee complaint
An anonymous, non-contactable complainant (described as an AstraZeneca UK marketing company employee) alleged AstraZeneca’s global functions did not receive appropriate ABPI Code training and tha…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3123/11/18
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka Europe voluntary admission
An Otsuka employee alleged Otsuka Europe was not transparent in its June 2018 response to the PMCPA in relation to earlier concerns about implementing SPC/prescribing information updates for Jinarc…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3041/6/18
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Employee complaint
An Otsuka employee complained that processes for updating SPCs and prescribing information were inadequate, leading to delayed communication/implementation and potential patient safety risk. Produc…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2927/1/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
BBC ‘landmark’ headline for unlicensed ocrelizumab trials
An anonymous, non-contactable complainant challenged a BBC website article (22 Dec 2016) titled ‘Multiple sclerosis drug “a landmark”’ about two Phase III trials of Roche’s unlicensed med…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2935/2/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sunovion
An anonymous ex-employee alleged a regional business manager (RBM) encouraged sales staff to pressure customers to prescribe Latuda (lurasidone) by suggesting prescribers could be sued if Latuda wa…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2926/1/17
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Stirling Anglian
A pharmaceutical physician complained that Stirling Anglian’s health professional website described Stirlescent (naproxen effervescent tablets) and theiCal-D3 (1000mg/880IU chewable tablet) as �…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2925/1/17
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer websites
A health professional complained about Pfizer websites, alleging out-of-date prescribing information (PI) across multiple items.Items cited: Vfend (voriconazole) leavepiece (ref VFE1771), Tygacil (…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2950/4/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Tor Generics
A health professional complained about a Tor Generics advertisement in The Big Issue (20–26 March 2017), a magazine sold to the general public.The ad included pack shots of Vitamin D3 capsules, V…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2946/3/17
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Merck Serono
An anonymous, non-contactable complainant (described as a consultant oncologist) complained about a Merck Serono representative’s conduct promoting Erbitux (cetuximab).Allegations included: frequ…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2945/3/17
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous community pharmacist complained about an NPA booklet, Managing COPD in the community, Resources for pharmacists (Ref UK/RET/0007/16), which carried both NPA and GlaxoSmithKline (GSK) l…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2942/2/17
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Online Spiolto banner ad (Pulse Today)
A health professional (consultant to a pharmaceutical company) complained in a private capacity about an online rolling banner advertisement for Spiolto (tiotropium and olodaterol) on Pulse Today.T…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2941/2/17
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A health professional (consultant to a pharmaceutical company; employing company named as Novartis in the report) complained in a private capacity about an email invitation to a live webcast from M…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2938/2/17
Data & Publications Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi v Novo Nordisk
Sanofi UK complained about a Novo Nordisk promotional leavepiece for Tresiba (insulin degludec) (ref UK/TB/1214/0302(4)).Page 3 headline claim: “Tresiba provides 75% less variability in glucose-l…
Clauses: 3.2,4.1,4.2
2017 🔒 Subscribe
← Prev 28 29 30 31 32 33 34 Next → Page 31 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews